LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,469,000 | -50.5% | 28,674 | -48.8% | 0.53% | +3.9% |
| Q2 2022 | $4,992,000 | +19.1% | 55,960 | +50.2% | 0.51% | -30.2% |
| Q1 2022 | $4,190,000 | -39.4% | 37,246 | -16.8% | 0.74% | -34.0% |
| Q4 2021 | $6,913,000 | +9.9% | 44,754 | -0.9% | 1.12% | -7.8% |
| Q3 2021 | $6,291,000 | +15.3% | 45,153 | +8.5% | 1.21% | +15.0% |
| Q2 2021 | $5,458,000 | -18.7% | 41,600 | -5.5% | 1.05% | -22.3% |
| Q1 2021 | $6,712,000 | +100.9% | 44,028 | +31.1% | 1.35% | +86.2% |
| Q4 2020 | $3,341,000 | +90.7% | 33,594 | +82.8% | 0.73% | +66.5% |
| Q3 2020 | $1,752,000 | – | 18,375 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |